News roundup Monday, July 8

Mellozza has received marketing approval in Switzerland. Read more.

BrainCool announces that the first patient has been treated with RhinoChill System in the pivotal COTTIS 2 study. Read more.

SmartCella raises EUR 50 million to accelerate growth and commercialization. Read more.

Last day for trading BTU in Respirator is July 10nd. Read more.

Bio Vitos Pharma is applying for ethical review for a new study on iron succinate and women's health. Read moreThe company announces changes in management. Read more.

Orthoma receives an additional milestone payment of USD 600. Read more.

PHI applies for listing on OTCQB in the United States. Read more.

The board of directors Carbiotix proposes a directed new share issue of a maximum of approximately SEK 7 million. Read more.

Acarix receives further orders from In-Home Concierge Practice. Read more.

PMDS carries out a rights issue of approximately SEK 27,5 million. Read more.

Scientific review article summarizes PExAs technology. Read more.

The board of directors Ray Intelligence decides on a directed new share issue. Read more.

Melissa Grant new member of AegirBios scientific advice. Read more.

The equity in Ecti Research less than half of the registered share capital and the board will call a first control meeting. Read more.

Getinge extends and deepens the collaboration with Universeum. Read more.

ArcticZymes announces an increase in share capital. Read more.